The cardiac assist devices and equipment market size has grown strongly in recent years. It will grow from $2.35 billion in 2025 to $2.53 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rising prevalence of advanced heart failure, expansion of cardiac surgery programs, increasing use of mechanical circulatory support, improvements in implantable device design, growing availability of specialized cardiac care centers.
The cardiac assist devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for destination therapy devices, rising adoption of remote monitoring-enabled assist systems, expansion of bridge-to-transplant applications, growing investments in next-generation cardiac devices, advancements in biocompatible materials and device miniaturization. Major trends in the forecast period include increasing adoption of implantable assist devices, rising use of minimally invasive cardiac support systems, growing integration of remote patient monitoring, expansion of pediatric and specialized cardiac devices, enhanced focus on long-term device reliability.
A rise in the prevalence of cardiovascular diseases (CVD) is boosting the demand for cardiac assist devices and equipment in both developed and developing countries. The growing need for diagnosis, monitoring, early-stage treatment, and prevention of these life-threatening conditions is driving demand for cardiac assist devices. For example, according to the American Heart Association, by 2035, approximately 45.1% of the U.S. population is expected to have some form of CVD. The total costs associated with CVD are projected to reach $1.1 trillion in 2035, with direct medical expenses estimated at $748.7 billion and indirect costs around $368 billion. Therefore, the increasing prevalence of cardiovascular diseases is fueling the growth of the cardiac assist devices and equipment market.
Major companies operating in the cardiac assist devices and equipment market are focusing on developing miniaturized interventional ventricular assist devices (VADs), such as foldable percutaneous VAD systems, to provide less-invasive circulatory support during high-risk percutaneous coronary interventions and acute cardiogenic shock. A foldable percutaneous VAD system is a catheter-delivered mechanical circulatory-support device designed for insertion through a small arterial sheath (reducing vascular access size), offering rapid left-ventricular unloading at clinically meaningful flow rates and minimizing procedural trauma compared with larger surgical pumps. For instance, in September 2023, magAssist, a China-based developer of circulatory-support devices, introduced the NyokAssist interventional ventricular assist device, which received U.S. FDA Breakthrough Device designation and completed first-in-human use. This small-bore (≈9 Fr) foldable catheter pump features an external motor to reduce hemolysis risk, is designed for straightforward delivery across the aortic arch, and achieved >3 L/min average flow during reported first-in-human high-risk PCI support.
In June 2023, Translumina, a Germany-based interventional cardiovascular device manufacturer, acquired Blue Medical Devices for an undisclosed amount. Through this acquisition, Translumina gained access to Blue Medical’s drug application technology, which ensures zero drug loss during device delivery and provides a high drug concentration precisely at the target site. The acquisition also allows Translumina to incorporate this patented technology across its broader portfolio, including peripheral and neurovascular intervention products. Blue Medical Devices is a Netherlands-based company specializing in cardiac assist devices and equipment.
Major companies operating in the cardiac assist devices and equipment market are Abbott Laboratories, Berlin Heart GmbH, Abiomed Inc., Bivacor Pvt. Ltd., Calon Cardio-Technology Ltd., Cardiobridge GmbH, Cardiac Assist Inc., Braile Biomedica Ltd., Circulite Inc., Evaheart Inc., FineHeart Sarl, Getinge AB, Jarvik Heart Inc., Medtronic plc, OregonHeart, MitiHeart Corporation, Procyrion Inc., Scandinavian Real Heart AB, Syncardia Systems LLC, HeartWare International Inc., Cardiac Power Innovations, Cardionomic Inc., Carmat SA, CorWave SA, Leviticus Cardio Ltd., LivaNova PLC, MicroMed Cardiovascular Inc., Novacor SA, Thoratec Corporation, Ventracor Limited.
North America was the largest region in global cardiac assist devices and equipment market in 2025. Western Europe was the second-largest region in cardiac assist devices and equipment market. The regions covered in the cardiac assist devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac assist devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the cardiac assist devices and equipment market by increasing costs of imported electromechanical components, precision sensors, biocompatible materials, control systems, and power units. Hospitals and cardiac care centers in North America and Europe are most affected due to reliance on imported high-end medical devices, while Asia-Pacific faces increased costs for advanced device procurement. These tariffs are elevating treatment costs and slowing device adoption in some regions. However, they are also driving local manufacturing initiatives, regional supplier development, and innovation in cost-optimized cardiac assist technologies.
The cardiac assist devices and equipment market research report is one of a series of new reports that provides cardiac assist devices and equipment market statistics, including cardiac assist devices and equipment industry global market size, regional shares, competitors with a cardiac assist devices and equipment market share, detailed cardiac assist devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac assist devices and equipment industry. This cardiac assist devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiac assist devices and equipment are electromechanical devices designed to aid in pumping blood from the heart to the rest of the body. These devices are used to either partially or fully replace the function of a failing heart. They help enhance blood circulation, alleviate the heart's workload, and can even provide life-saving support in critical situations.
Key types of cardiac assist devices include ventricular assist devices, intra-aortic balloon pumps, and the total artificial heart. Ventricular assist devices are specifically designed electromechanical tools for heart circulation support. These devices come in varied forms, such as transcutaneous and implantable, and find application in hospital pharmacies, ambulatory surgical centers, and emergency services.
The cardiac assist devices and equipment market consist of sales of ventricular assist devices (LVAD), intra-aortic balloon pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cardiac assist devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for destination therapy devices, rising adoption of remote monitoring-enabled assist systems, expansion of bridge-to-transplant applications, growing investments in next-generation cardiac devices, advancements in biocompatible materials and device miniaturization. Major trends in the forecast period include increasing adoption of implantable assist devices, rising use of minimally invasive cardiac support systems, growing integration of remote patient monitoring, expansion of pediatric and specialized cardiac devices, enhanced focus on long-term device reliability.
A rise in the prevalence of cardiovascular diseases (CVD) is boosting the demand for cardiac assist devices and equipment in both developed and developing countries. The growing need for diagnosis, monitoring, early-stage treatment, and prevention of these life-threatening conditions is driving demand for cardiac assist devices. For example, according to the American Heart Association, by 2035, approximately 45.1% of the U.S. population is expected to have some form of CVD. The total costs associated with CVD are projected to reach $1.1 trillion in 2035, with direct medical expenses estimated at $748.7 billion and indirect costs around $368 billion. Therefore, the increasing prevalence of cardiovascular diseases is fueling the growth of the cardiac assist devices and equipment market.
Major companies operating in the cardiac assist devices and equipment market are focusing on developing miniaturized interventional ventricular assist devices (VADs), such as foldable percutaneous VAD systems, to provide less-invasive circulatory support during high-risk percutaneous coronary interventions and acute cardiogenic shock. A foldable percutaneous VAD system is a catheter-delivered mechanical circulatory-support device designed for insertion through a small arterial sheath (reducing vascular access size), offering rapid left-ventricular unloading at clinically meaningful flow rates and minimizing procedural trauma compared with larger surgical pumps. For instance, in September 2023, magAssist, a China-based developer of circulatory-support devices, introduced the NyokAssist interventional ventricular assist device, which received U.S. FDA Breakthrough Device designation and completed first-in-human use. This small-bore (≈9 Fr) foldable catheter pump features an external motor to reduce hemolysis risk, is designed for straightforward delivery across the aortic arch, and achieved >3 L/min average flow during reported first-in-human high-risk PCI support.
In June 2023, Translumina, a Germany-based interventional cardiovascular device manufacturer, acquired Blue Medical Devices for an undisclosed amount. Through this acquisition, Translumina gained access to Blue Medical’s drug application technology, which ensures zero drug loss during device delivery and provides a high drug concentration precisely at the target site. The acquisition also allows Translumina to incorporate this patented technology across its broader portfolio, including peripheral and neurovascular intervention products. Blue Medical Devices is a Netherlands-based company specializing in cardiac assist devices and equipment.
Major companies operating in the cardiac assist devices and equipment market are Abbott Laboratories, Berlin Heart GmbH, Abiomed Inc., Bivacor Pvt. Ltd., Calon Cardio-Technology Ltd., Cardiobridge GmbH, Cardiac Assist Inc., Braile Biomedica Ltd., Circulite Inc., Evaheart Inc., FineHeart Sarl, Getinge AB, Jarvik Heart Inc., Medtronic plc, OregonHeart, MitiHeart Corporation, Procyrion Inc., Scandinavian Real Heart AB, Syncardia Systems LLC, HeartWare International Inc., Cardiac Power Innovations, Cardionomic Inc., Carmat SA, CorWave SA, Leviticus Cardio Ltd., LivaNova PLC, MicroMed Cardiovascular Inc., Novacor SA, Thoratec Corporation, Ventracor Limited.
North America was the largest region in global cardiac assist devices and equipment market in 2025. Western Europe was the second-largest region in cardiac assist devices and equipment market. The regions covered in the cardiac assist devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac assist devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the cardiac assist devices and equipment market by increasing costs of imported electromechanical components, precision sensors, biocompatible materials, control systems, and power units. Hospitals and cardiac care centers in North America and Europe are most affected due to reliance on imported high-end medical devices, while Asia-Pacific faces increased costs for advanced device procurement. These tariffs are elevating treatment costs and slowing device adoption in some regions. However, they are also driving local manufacturing initiatives, regional supplier development, and innovation in cost-optimized cardiac assist technologies.
The cardiac assist devices and equipment market research report is one of a series of new reports that provides cardiac assist devices and equipment market statistics, including cardiac assist devices and equipment industry global market size, regional shares, competitors with a cardiac assist devices and equipment market share, detailed cardiac assist devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac assist devices and equipment industry. This cardiac assist devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiac assist devices and equipment are electromechanical devices designed to aid in pumping blood from the heart to the rest of the body. These devices are used to either partially or fully replace the function of a failing heart. They help enhance blood circulation, alleviate the heart's workload, and can even provide life-saving support in critical situations.
Key types of cardiac assist devices include ventricular assist devices, intra-aortic balloon pumps, and the total artificial heart. Ventricular assist devices are specifically designed electromechanical tools for heart circulation support. These devices come in varied forms, such as transcutaneous and implantable, and find application in hospital pharmacies, ambulatory surgical centers, and emergency services.
The cardiac assist devices and equipment market consist of sales of ventricular assist devices (LVAD), intra-aortic balloon pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cardiac Assist Devices and Equipment Market Characteristics
3. Cardiac Assist Devices and Equipment Market Supply Chain Analysis
4. Global Cardiac Assist Devices and Equipment Market Trends and Strategies
5. Cardiac Assist Devices and Equipment Market Analysis of End Use Industries
7. Global Cardiac Assist Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cardiac Assist Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Cardiac Assist Devices and Equipment Market Segmentation
10. Cardiac Assist Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Cardiac Assist Devices and Equipment Market
12. China Cardiac Assist Devices and Equipment Market
13. India Cardiac Assist Devices and Equipment Market
14. Japan Cardiac Assist Devices and Equipment Market
15. Australia Cardiac Assist Devices and Equipment Market
16. Indonesia Cardiac Assist Devices and Equipment Market
17. South Korea Cardiac Assist Devices and Equipment Market
18. Bangladesh Cardiac Assist Devices and Equipment Market
19. Thailand Cardiac Assist Devices and Equipment Market
20. Vietnam Cardiac Assist Devices and Equipment Market
21. Malaysia Cardiac Assist Devices and Equipment Market
22. Singapore Cardiac Assist Devices and Equipment Market
23. Philippines Cardiac Assist Devices and Equipment Market
24. Hong Kong Cardiac Assist Devices and Equipment Market
25. New Zealand Cardiac Assist Devices and Equipment Market
26. Taiwan Cardiac Assist Devices and Equipment Market
27. South East Asia Cardiac Assist Devices and Equipment Market
28. Western Europe Cardiac Assist Devices and Equipment Market
29. UK Cardiac Assist Devices and Equipment Market
30. Germany Cardiac Assist Devices and Equipment Market
31. France Cardiac Assist Devices and Equipment Market
32. Italy Cardiac Assist Devices and Equipment Market
33. Spain Cardiac Assist Devices and Equipment Market
34. Austria Cardiac Assist Devices and Equipment Market
35. Belgium Cardiac Assist Devices and Equipment Market
36. Denmark Cardiac Assist Devices and Equipment Market
37. Finland Cardiac Assist Devices and Equipment Market
38. Ireland Cardiac Assist Devices and Equipment Market
39. Netherlands Cardiac Assist Devices and Equipment Market
40. Norway Cardiac Assist Devices and Equipment Market
41. Portugal Cardiac Assist Devices and Equipment Market
42. Sweden Cardiac Assist Devices and Equipment Market
42. Switzerland Cardiac Assist Devices and Equipment Market
43. Eastern Europe Cardiac Assist Devices and Equipment Market
44. Russia Cardiac Assist Devices and Equipment Market
45. Czech Republic Cardiac Assist Devices and Equipment Market
46. Poland Cardiac Assist Devices and Equipment Market
47. Romania Cardiac Assist Devices and Equipment Market
48. Ukraine Cardiac Assist Devices and Equipment Market
49. North America Cardiac Assist Devices and Equipment Market
50. USA Cardiac Assist Devices and Equipment Market
51. Canada Cardiac Assist Devices and Equipment Market
52. Mexico Cardiac Assist Devices and Equipment Market
53. South America Cardiac Assist Devices and Equipment Market
54. Brazil Cardiac Assist Devices and Equipment Market
55. Chile Cardiac Assist Devices and Equipment Market
56. Argentina Cardiac Assist Devices and Equipment Market
57. Colombia Cardiac Assist Devices and Equipment Market
58. Peru Cardiac Assist Devices and Equipment Market
59. Middle East Cardiac Assist Devices and Equipment Market
60. Saudi Arabia Cardiac Assist Devices and Equipment Market
61. Israel Cardiac Assist Devices and Equipment Market
62. Iran Cardiac Assist Devices and Equipment Market
63. Turkey Cardiac Assist Devices and Equipment Market
64. United Arab Emirates Cardiac Assist Devices and Equipment Market
65. Africa Cardiac Assist Devices and Equipment Market
66. Egypt Cardiac Assist Devices and Equipment Market
67. Nigeria Cardiac Assist Devices and Equipment Market
68. South Africa Cardiac Assist Devices and Equipment Market
70. Cardiac Assist Devices and Equipment Market Competitive Landscape and Company Profiles
71. Cardiac Assist Devices and Equipment Market Other Major and Innovative Companies
74. Cardiac Assist Devices and Equipment Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Cardiac Assist Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cardiac assist devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiac assist devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac assist devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Ventricular Assist Devices (LVAD); Intra-Aotic Baloon Pumps; Total Artificial Heart2) By Modality: Transcutaneous; Implantable
3) By Application: Hospitals And Cardiac Care Centers; Ambulatory Surgical Centres; Emergency Services
Subsegments:
1) By Ventricular Assist Devices (LVAD): Implantable LVADs; Externally Powered LVADs; Pediatric LVADs; Other LVADs2) By Intra-Aortic Balloon Pumps: Disposable Intra-Aortic Balloon Pumps; Reusable Intra-Aortic Balloon Pumps
3) By Total Artificial Heart: Pneumatically Powered Total Artificial Heart; Electrically Powered Total Artificial Heart; Other Total Artificial Heart Types
Companies Mentioned: Abbott Laboratories; Berlin Heart GmbH; Abiomed Inc.; Bivacor Pvt. Ltd.; Calon Cardio-Technology Ltd.; Cardiobridge GmbH; Cardiac Assist Inc.; Braile Biomedica Ltd.; Circulite Inc.; Evaheart Inc.; FineHeart Sarl; Getinge AB; Jarvik Heart Inc.; Medtronic plc; OregonHeart; MitiHeart Corporation; Procyrion Inc.; Scandinavian Real Heart AB; Syncardia Systems LLC; HeartWare International Inc.; Cardiac Power Innovations; Cardionomic Inc.; Carmat SA; CorWave SA; Leviticus Cardio Ltd.; LivaNova PLC; MicroMed Cardiovascular Inc.; Novacor SA; Thoratec Corporation; Ventracor Limited
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cardiac Assist Devices and Equipment market report include:- Abbott Laboratories
- Berlin Heart GmbH
- Abiomed Inc.
- Bivacor Pvt. Ltd.
- Calon Cardio-Technology Ltd.
- Cardiobridge GmbH
- Cardiac Assist Inc.
- Braile Biomedica Ltd.
- Circulite Inc.
- Evaheart Inc.
- FineHeart Sarl
- Getinge AB
- Jarvik Heart Inc.
- Medtronic plc
- OregonHeart
- MitiHeart Corporation
- Procyrion Inc.
- Scandinavian Real Heart AB
- Syncardia Systems LLC
- HeartWare International Inc.
- Cardiac Power Innovations
- Cardionomic Inc.
- Carmat SA
- CorWave SA
- Leviticus Cardio Ltd.
- LivaNova PLC
- MicroMed Cardiovascular Inc.
- Novacor SA
- Thoratec Corporation
- Ventracor Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.53 Billion |
| Forecasted Market Value ( USD | $ 3.76 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
